Commencing in 1988 with software development, David and a partner launched in 1995 what would become a highly successful Managed Services Provider, delivering IT services for a range of customers including some of Australia’s most recognisable public and privately held brands. He sold his interest in the business in 2011 and continues to provide Strategic IT Consulting Services to selected clients including Not-For-Profit organisations and government agencies.
Michelle is passionate about the Not-for-Profit sector and has worked for the Australian Association of Social Workers and the Council on the Ageing (NSW). She has a Bachelor of Arts degree majoring in Politics from Macquarie University and a Bachelor of Social Work degree from Charles Sturt University.
Michelle is looking forward to developing relationships with Trusts and Foundations, and within the Government sector, to enhance support and generate revenue for Epilepsy Action Australia’s core programs and objectives.
Kerry has almost 15 years experience in her field and has worked with some of the biggest brands/organisations in the world, including Shell, MasterCard, Samsung, Starbucks and Hilton. In her current role, Kerry is responsible for developing and managing Epilepsy Action Australia’s external relationships and fundraising activities targeting the community and corporate sector to raise revenue and grow the organisation’s profile.
Lisa came to Epilepsy Action Australia with extensive experience in neuroscience and intensive care nursing, along with nurse education, which was utilised in the development of Epilepsy Action Australia’s Online Academy courses and resources. In her development work Lisa has utilised the experience gained during two periods of secondment: to the East Timor Epilepsy Project and the George Institute for Global Health.
More recently Anuradha has held the position of Business Process Manager responsible for process improvements across the organisation’s functions, and in July 2016 he was promoted to Business Manager, managing day-to-day operations within the organisation as well as providing strategic input into the ongoing direction of the organisation.
She currently sits on the Australian Advisory Council on the Medicinal Use of Cannabis, the Advisory Board of the Lambert Initiative for Cannabinoid Therapeutics at the University of Sydney, and the Steering Committee for the NSW Government’s Paediatric Epilepsy Trials (Medicinal Cannabis Research). She is fully responsible for all operations of the company within the established policies, and in accordance with the authority delegated by the Board of Directors implements the strategic goals and objectives, giving direction and leadership toward the achievement of the organisation’s mission and strategy.